Your browser is no longer supported. Please, upgrade your browser.
Settings
CRMD CorMedix, Inc. daily Stock Chart
CRMD [NYSE]
CorMedix, Inc.
Index- P/E- EPS (ttm)-0.56 Insider Own0.60% Shs Outstand80.09M Perf Week40.65%
Market Cap174.60M Forward P/E- EPS next Y-0.14 Insider Trans0.00% Shs Float- Perf Month282.46%
Income-39.00M PEG- EPS next Q-0.06 Inst Own12.40% Short Float- Perf Quarter735.57%
Sales0.20M P/S872.98 EPS this Y7.80% Inst Trans- Short Ratio1.73 Perf Half Y928.79%
Book/sh-0.08 P/B- EPS next Y56.20% ROA-363.60% Target Price3.00 Perf Year241.59%
Cash/sh0.06 P/C37.15 EPS next 5Y- ROE- 52W Range0.17 - 2.40 Perf YTD334.26%
Dividend- P/FCF- EPS past 5Y-15.10% ROI- 52W High-25.83% Beta1.10
Dividend %- Quick Ratio0.40 Sales past 5Y- Gross Margin64.40% 52W Low934.28% ATR0.23
Employees14 Current Ratio0.50 Sales Q/Q-94.50% Oper. Margin- RSI (14)67.14 Volatility28.75% 18.47%
OptionableYes Debt/Eq- EPS Q/Q-6.20% Profit Margin- Rel Volume1.39 Prev Close2.18
ShortableNo LT Debt/Eq- EarningsNov 13 AMC Payout- Avg Volume5.02M Price1.78
Recom2.00 SMA2053.72% SMA50127.09% SMA200307.06% Volume4,955,980 Change-18.35%
Sep-25-17Reiterated H.C. Wainwright Buy $3 → $4
Aug-10-17Reiterated Rodman & Renshaw Buy $5 → $3
May-05-17Reiterated Rodman & Renshaw Buy $6 → $5
Nov-11-16Reiterated FBR & Co. Outperform $6 → $4
Mar-17-16Reiterated FBR Capital Outperform $7 → $6
Mar-03-16Initiated FBR Capital Outperform $7
Nov-16-15Reiterated ROTH Capital Neutral $2.75 → $2.50
Oct-29-15Reiterated ROTH Capital Neutral $4.50 → $2.75
May-06-15Downgrade ROTH Capital Buy → Neutral $2.50 → $7.50
Dec-08-14Reiterated ROTH Capital Buy $3 → $2.50
Oct-03-11Downgrade Maxim Group Buy → Hold
Oct-01-18 07:13AM  What Kind Of Shareholders Own CorMedix Inc (NYSEMKT:CRMD)? Simply Wall St. +22.85%
Aug-31-18 04:15PM  CorMedix Announces NYSE American Acceptance of Plan to Regain Listing Compliance ACCESSWIRE +5.44%
Aug-30-18 08:00AM  CorMedix Inc. to Present at The 20th Annual Rodman & Renshaw Global Investment Conference ACCESSWIRE +7.52%
Aug-27-18 07:40AM  Analysis: Positioning to Benefit within C&J Energy Services, LivePerson, Kadmon, Cara Therapeutics, CorMedix, and Second Sight Medical Products Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +9.44%
Aug-14-18 06:09PM  CorMedix: 2Q Earnings Snapshot Associated Press -8.20%
04:05PM  CorMedix Inc. Reports Second Quarter Financial Results and Provides Business Update ACCESSWIRE
02:30PM  CorMedix Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 08:00AM  CorMedix Inc. to Report Second Quarter 2018 Financial Results on Tuesday, August 14 ACCESSWIRE +15.37%
Jul-26-18 08:10AM  Today's Research Reports on Stocks to Watch: USANA Health Sciences and CorMedix ACCESSWIRE +31.90%
Jul-25-18 07:30AM  Cormedix Inc. Announces Positive Results Of Its Neutrolin(R) Phase 3 Lock-It-100 Study Based On Recommendation By Independent Data Safety Monitoring Board ACCESSWIRE +16.43%
Jul-24-18 07:55AM  Free Research Reports on CorMedix and Three More Biotech Stocks ACCESSWIRE
Jun-26-18 07:30AM  Report: Exploring Fundamental Drivers Behind Chegg, C.H. Robinson Worldwide, Republic Services, CorMedix, Burlington Stores, and Etsy New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jun-25-18 07:05AM  Today's Free Research Reports Coverage on CorMedix and Three More Biotech Stocks ACCESSWIRE -6.37%
Jun-20-18 07:30AM  Cormedix Inc. Completes Review and Source Verification of Phase 3 Lock-It 100 Data For Neutrolin(R) ACCESSWIRE
Jun-19-18 04:15PM  Cormedix Inc. Receives a Continued Listing Standard Notice from the NYSE American ACCESSWIRE
May-30-18 08:35AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +23.78%
May-29-18 04:30PM  CorMedix, Inc. Reports Progress on LOCK- IT 100 Data Review and Appoints Paul Chew as Consultant Advisor CMO ACCESSWIRE
May-25-18 04:25PM  With A -26.58% Earnings Drop, Did CorMedix Inc (NYSEMKT:CRMD) Really Underperform? Simply Wall St. +5.39%
May-15-18 04:05PM  Cormedix Inc. Reports First Quarter Financial Results and Provides Business Update ACCESSWIRE
May-09-18 08:20AM  Report: Exploring Fundamental Drivers Behind CorMedix, U.S. Silica, Zoetis, Kansas City Southern, Bemis, and Flowserve New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
08:00AM  CorMedix Inc. to Report First Quarter 2018 Financial Results on Tuesday, May 15 ACCESSWIRE
Apr-27-18 08:00AM  CorMedix Revises Timeline and Announces Changes to Lock-It-100 Study Management ACCESSWIRE +6.51%
Mar-20-18 05:00PM  CorMedix Inc. Makes NYSE American Section 610(b) Public Announcement ACCESSWIRE -12.63%
Mar-19-18 04:05PM  Cormedix Inc. Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Business Update ACCESSWIRE -6.11%
12:00PM  CorMedix Inc. to Host Earnings Call ACCESSWIRE
Mar-13-18 08:00AM  CorMedix Inc. to Report Fourth Quarter and Full Year 2017 Financial Results on Monday, March 19 ACCESSWIRE
Mar-07-18 08:25AM  Investor Expectations to Drive Momentum within AVEO Pharmaceuticals, PTC Therapeutics, NGL Energy Partners LP, Bemis, CorMedix, and Patterson Companies Discovering Underlying Factors of Influence GlobeNewswire
Feb-27-18 09:15AM  CorMedix Inc. Provides Update on Its Financing Plans in Connection with Its Ongoing LOCK-IT 100 Clinical Study ACCESSWIRE
Feb-26-18 08:00AM  CorMedix Inc. Granted Orphan Drug Designation for Taurolidine for Treatment of Neuroblastoma ACCESSWIRE -5.90%
Feb-20-18 01:53PM  Why CorMedix Inc. (CRMD) Shares Took a Nosedive Today SmarterAnalyst -32.19%
07:30AM  CorMedix Inc. Achieves Target Number of Events in Its LOCK-IT-100 Study of Neutrolin(R) for Interim Efficacy Analysis ACCESSWIRE
Jan-01-18 11:31AM  ETFs with exposure to CorMedix, Inc. : January 1, 2018 Capital Cube
Dec-27-17 08:43AM  CorMedix, Inc. :CRMD-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Dec-19-17 12:35PM  ETFs with exposure to CorMedix, Inc. : December 19, 2017 Capital Cube
Dec-07-17 01:22PM  ETFs with exposure to CorMedix, Inc. : December 7, 2017 Capital Cube
Dec-05-17 08:05AM  CorMedix Inc. Announces Acceptance of Final Post-Marketing Study Data to be Published in the European Journal of Clinical Microbiology and Infectious Diseases ACCESSWIRE
Dec-04-17 04:20PM  CorMedix Inc (CRMD): Should The Recent EPS Drop Worry You? Simply Wall St. +17.60%
Nov-29-17 08:05AM  CorMedix Inc. to Host Seminar on Hemodialysis Catheter Complications at 17th Annual Conference on Nephrology ACCESSWIRE
Nov-20-17 08:20AM  CorMedix Inc. Announces Common Stock Purchase by Company Directors and Executive Management Team ACCESSWIRE
Nov-13-17 08:00AM  Factors of Influence in 2018, Key Indicators and Opportunity within CorMedix, RPC, Royal Caribbean Cruises, Callaway Golf, CIT Group, and Cars.com New Research Emphasizes Economic Growth GlobeNewswire -7.36%
Nov-09-17 04:15PM  CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update ACCESSWIRE
04:15PM  CorMedix Inc. Enters into $5 Million Combined Securities Purchase and Backstop Agreement with Existing Investor ACCESSWIRE
12:05PM  CorMedix Inc. to Host Earnings Call ACCESSWIRE
Nov-07-17 10:04AM  ETFs with exposure to CorMedix, Inc. : November 7, 2017 Capital Cube
08:05AM  CorMedix Inc. to Report Third Quarter 2017 Financial Results and Provide Business Update ACCESSWIRE
Oct-26-17 04:07PM  CorMedix Inc. to Present Candida auris Susceptibility Data at 2nd Annual Gulf Congress of Clinical Microbiology and Infectious Diseases ACCESSWIRE
Oct-12-17 10:23AM  ETFs with exposure to CorMedix, Inc. : October 12, 2017 Capital Cube -9.51%
Oct-11-17 07:34PM  Is There Now An Opportunity In CorMedix Inc (CRMD)? Simply Wall St. +15.76%
Sep-28-17 08:05AM  CorMedix Inc. to Present at The MicroCap Conference ACCESSWIRE
Sep-25-17 08:05AM  CorMedix Inc. Relocates Corporate Headquarters ACCESSWIRE
Sep-21-17 12:15PM  CorMedix Inc. to Present at The MicroCap Conference on October 5th in New York City at the Essex House ACCESSWIRE
Sep-12-17 08:17AM  CorMedix Inc. to Present at the Anti-Infectives Rx Conference ACCESSWIRE
Sep-07-17 04:05PM  CorMedix Inc. Presents Data Demonstrating Antimicrobial Activity of Taurolidine Against Potentially Deadly Fungal Pathogen Candida auris ACCESSWIRE
08:30AM  Are Options Traders Betting on a Big Move in CorMedix (CRMD) Stock? Zacks
Sep-05-17 04:45PM  CorMedix Inc. to Present at 2017 Rodman & Renshaw 19th Annual Global Investment Conference ACCESSWIRE -8.27%
Aug-31-17 05:55PM  ETFs with exposure to CorMedix, Inc. : August 31, 2017 Capital Cube
Aug-25-17 04:07PM  CorMedix Inc. Announces a Change to its Senior Leadership ACCESSWIRE +5.45%
Aug-24-17 10:37AM  CorMedix, Inc. :CRMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017 Capital Cube
Aug-17-17 09:17AM  CorMedix, Inc. Awarded NIH Grant to Develop Advanced Antimicrobial Hydrogels for the Treatment and Prevention of Potentially Life-Threatening Infections in Severe Burns ACCESSWIRE +10.33%
Aug-16-17 08:36AM  Is the Options Market Predicting a Spike in CorMedix (CRMD) Stock? Zacks
Aug-09-17 04:10PM  CorMedix Inc. Reports Second Quarter Financial Results and Provides Business Update ACCESSWIRE
12:00PM  Investor Network: CorMedix Inc. to Host Earnings Call ACCESSWIRE
Aug-07-17 08:47AM  CorMedix Inc. Appoints Gary Gelbfish, M.D., to Board of Directors ACCESSWIRE +5.64%
Aug-04-17 02:46PM  CorMedix Inc. to Report Second Quarter 2017 Financial Results and Provide Business Update ACCESSWIRE
Aug-02-17 09:05AM  CorMedix Inc. Provides Update on Neutrolin(R) Ongoing Phase 3 Clinical Trial Following Favorable FDA Correspondence ACCESSWIRE +7.49%
Jul-14-17 08:32AM  Implied Volatility Surging For CorMedix Inc (CRMD) Stock Options Zacks
Jul-12-17 08:30AM  CorMedix Inc. Provides Comprehensive Pipeline Update During Research and Development Day Accesswire -5.17%
Jun-26-17 08:05AM  CorMedix Inc. Appoints Mehmood Khan, M.D. and Steven Lefkowitz to its Board of Directors Accesswire
Jun-23-17 08:47AM  Implied Volatility Surging for CorMedix (CRMD) Stock Options Zacks
Jun-16-17 03:35PM  ETFs with exposure to CorMedix, Inc. : June 16, 2017 Capital Cube -7.53%
Jun-14-17 09:15AM  CorMedix Inc. to Showcase Its Taurolidine-Based Development Pipeline at Research and Development Day Accesswire
Jun-12-17 11:13AM  CorMedix Inc. Announces Changes to Board of Directors Accesswire
May-31-17 09:00AM  Implied Volatility Surging for CorMedix (CRMD) Stock Options Zacks
May-26-17 01:03PM  ETFs with exposure to CorMedix, Inc. : May 26, 2017 Capital Cube
12:09PM  INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of CorMedix, Inc. Business Wire
May-15-17 03:32PM  ETFs with exposure to CorMedix, Inc. : May 15, 2017 Capital Cube +5.46%
May-12-17 11:59AM  CorMedix, Inc. :CRMD-US: Earnings Analysis: Q1, 2017 By the Numbers : May 12, 2017 Capital Cube
May-10-17 04:05PM  CorMedix Inc. Reports First Quarter Financial Results and Provides Business Update Accesswire
May-09-17 08:05AM  CorMedix Inc. Demonstrates Sensitivity of Emerging Global Health Threat Candida auris to Taurolidine Accesswire +5.24%
May-05-17 02:00PM  CorMedix Inc. to Report First Quarter 2017 Financial Results and Provide Business Update Accesswire
May-03-17 04:30PM  CorMedix Inc. Announces Closing of Public Offering of Common Stock and Warrants and Underwriter's Exercise in Full of Over-Allotment Option Accesswire
May-01-17 08:46AM  Implied Volatility Surging for CorMedix (CRMD) Stock Options Zacks
Apr-28-17 06:30AM  CorMedix Inc. Increases Previously Announced Public Offering to $12.1 Million Accesswire -38.45%
Apr-27-17 05:08PM  CorMedix Inc. Announces $10 Million Underwritten Public Offering Accesswire -6.31%
Apr-24-17 06:19PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of CorMedix, Inc. Business Wire
Apr-20-17 08:05AM  CorMedix Inc. Reports Update on Neutrolin(R) Phase 3 LOCK-IT 100 Clinical Trial Accesswire
Apr-12-17 08:05AM  CorMedix Inc. Secures First European Commercial Collaboration for Neutrolin(R) Accesswire +14.42%
Apr-10-17 01:44PM  ETFs with exposure to CorMedix, Inc. : April 10, 2017 Capital Cube -5.80%
Mar-30-17 08:37AM  Are Options Traders Betting on a Big Move in CorMedix (CRMD) Stock? Zacks
08:37AM  Are Options Traders Betting on a Big Move in CorMedix (CRMD) Stock? at Investopedia
Mar-23-17 08:00PM  CorMedix Inc. Makes NYSE MKT Section 610(b) Public Announcement Accesswire +11.54%
Mar-22-17 01:04PM  CORMEDIX INC. Financials
Mar-21-17 11:36AM  CorMedix, Inc. :CRMD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Capital Cube -9.09%
11:36AM  CorMedix, Inc. :CRMD-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
09:57AM  CorMedix, Inc. :CRMD-US: Earnings Analysis: 2016 By the Numbers : March 21, 2017
Mar-17-17 08:52AM  CorMedix's stock plunges after warning that it may run out of cash MarketWatch -13.04%
08:52AM  CorMedix's stock plunges after warning that it may run out of cash at MarketWatch
08:20AM  CORMEDIX INC. Files SEC form 8-K, Results of Operations and Financial Condition
08:05AM  CorMedix Inc. Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update Accesswire
Mar-10-17 02:25PM  CorMedix Inc. to Report Fourth Quarter and Full Year 2017 Financial Results and Provide Business Update Accesswire
CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its primary focus is on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kaplan MyronDirectorFeb 21Option Exercise0.0010,0000294,166Mar 22 04:03 PM
Dillione JanetDirectorFeb 21Option Exercise0.0015,3570107,409Mar 22 04:01 PM
ARMSTRONG JR. JOHN L.Exec VP of Tech OperationsDec 31Option Exercise0.0018,028038,861Mar 22 04:02 PM
Kaplan MyronDirectorDec 12Buy0.48104,16650,000284,166Dec 14 04:29 PM
Lefkowitz Steven WDirectorDec 12Buy0.48135,41665,000195,379Dec 14 04:15 PM
Dillione JanetDirectorDec 12Buy0.4852,08325,00092,052Dec 14 04:13 PM
Gelbfish Gary A.DirectorDec 12Buy0.4852,08325,0002,101,121Dec 14 04:12 PM
Khan MehmoodDirectorDec 12Buy0.4852,08325,000452,083Dec 14 04:11 PM
Cook Robert W.Chief Financial OfficerDec 12Buy0.4852,08325,000102,083Dec 14 04:09 PM
ARMSTRONG JR. JOHN L.Exec VP of Tech OperationsDec 12Buy0.4820,83310,00020,833Dec 14 04:08 PM
Baluch KhosoChief Executive OfficerDec 12Buy0.48104,16650,000225,373Dec 14 04:06 PM